BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Joish VN, Perez-olle R, Lapuerta P, Dharba S, Zacks J. Burden of Carcinoid Heart Disease in Patients With Carcinoid Syndrome Initiating Somatostatin Analogues. Clinical Therapeutics 2019;41:1716-1723.e2. [DOI: 10.1016/j.clinthera.2019.06.013] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Laskaratos FM, Davar J, Toumpanakis C. Carcinoid Heart Disease: a Review. Curr Oncol Rep 2021;23:48. [PMID: 33725214 DOI: 10.1007/s11912-021-01031-z] [Reference Citation Analysis]
2 Tanaka H, Uema D, Rego JFM, Weschenfelder RF, D'Agustini N, Filho DRR, O'Connor JM, Luca R, Nuñez JER, de Barros E Silva MJ, Riechelmann RP. Health resource utilisation by patients with neuroendocrine tumours with or without carcinoid heart disease: a multinational study. Ecancermedicalscience 2020;14:1141. [PMID: 33343700 DOI: 10.3332/ecancer.2020.1141] [Reference Citation Analysis]
3 Benson AB 3rd, Strosberg J, Joish VN, Dharba S, Sapre D, Lapuerta P. Clinical Benefits of Telotristat Ethyl in Patients With Neuroendocrine Tumors and Low Bowel Movement Frequency: An Observational Patient-Reported Outcomes Study. Pancreas 2020;49:408-12. [PMID: 32132510 DOI: 10.1097/MPA.0000000000001496] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]